» Articles » PMID: 15096048

Enhancement of the Endopeptidase Activity of Purified Botulinum Neurotoxins A and E by an Isolated Component of the Native Neurotoxin Associated Proteins

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2004 Apr 21
PMID 15096048
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

In botulism disease, neurotransmitter release is blocked by a group of structurally related neurotoxin proteins produced by Clostridium botulinum. Botulinum neurotoxins (BoNT, A-G) enter nerve terminals and irreversibly inhibit exocytosis via their endopeptidase activities against synaptic proteins SNAP-25, VAMP, and Syntaxin. Type A C. botulinum secretes the neurotoxin along with 5 other proteins called neurotoxin associated proteins (NAPs). Here, we report that hemagglutinin-33 (Hn-33), one of the NAP components, enhances the endopeptidase activity of not only BoNT/A but also that of BoNT/E, both under in vitro conditions and in rat synaptosomes. BoNT/A endopeptidase activity in vitro is about twice as high as that of BoNT/E under disulfide-reduced conditions. Addition of Hn-33 separately to nonreduced BoNT/A and BoNT/E (which otherwise have only residual endopeptidase activity) enhanced their in vitro endopeptidase activity by 21- and 25-fold, respectively. Cleavage of rat-brain synaptosome SNAP-25 by BoNTs was used to assay endopeptidase activity under nerve-cell conditions. Reduced BoNT/A and BoNT/E cleaved synaptosomal SNAP-25 by 20% and 15%, respectively. Addition of Hn-33 separately to nonreduced BoNT/A and BoNT/E enhanced their endopeptidase activities by 13-fold for the cleavage of SNAP-25 in synaptosomes, suggesting a possible functional role of Hn-33 in association with BoNTs. We believe that Hn-33 could be used as an activator in the formulation of the neurotoxin for therapeutic use.

Citing Articles

Update on Non-Interchangeability of Botulinum Neurotoxin Products.

Brin M, Nelson M, Ashourian N, Brideau-Andersen A, Maltman J Toxins (Basel). 2024; 16(6).

PMID: 38922160 PMC: 11209304. DOI: 10.3390/toxins16060266.


Clostridial Neurotoxins: Structure, Function and Implications to Other Bacterial Toxins.

Cai S, Kumar R, Singh B Microorganisms. 2021; 9(11).

PMID: 34835332 PMC: 8618262. DOI: 10.3390/microorganisms9112206.


Bioinformatics analysis and experimental validation of differentially expressed genes in mouse articular chondrocytes treated with IL-1β using microarray data.

Liang F, Peng L, Ma Y, Hu W, Zhang W, Deng M Exp Ther Med. 2021; 23(1):6.

PMID: 34815758 PMC: 8593859. DOI: 10.3892/etm.2021.10928.


The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: Key Clinical Postulates II.

Nestor M, Arnold D, Fischer D J Cosmet Dermatol. 2020; 19(11):2785-2804.

PMID: 32866999 PMC: 7693297. DOI: 10.1111/jocd.13702.


Role of critical elements in botulinum neurotoxin complex in toxin routing across intestinal and bronchial barriers.

Ghosal K, Patel K, Singh B, Hale M PLoS One. 2018; 13(7):e0199524.

PMID: 29975725 PMC: 6033393. DOI: 10.1371/journal.pone.0199524.